难以诊断的激素阴性、人表皮生长因子受体2阳性低分化乳腺癌1例男性患者

Annals of breast cancer and therapy Pub Date : 2020-03-12 DOI:10.36959/739/524

Kitada Masahiro, Yasuda Shunsuke, A. Masahiro, Yoshida Nana, Okazaki Satoshi, Ishibashi Kei

{"title":"难以诊断的激素阴性、人表皮生长因子受体2阳性低分化乳腺癌1例男性患者","authors":"Kitada Masahiro, Yasuda Shunsuke, A. Masahiro, Yoshida Nana, Okazaki Satoshi, Ishibashi Kei","doi":"10.36959/739/524","DOIUrl":null,"url":null,"abstract":"Male breast cancer is rare, accounting for approximately 0.5-1.0% of all cases and is often a hormone-dependent luminal type. The percentage of hormone-negative, human epidermal growth factor receptor 2 (HER2)-positive breast cancer cases is very small in male patients (0.6-1.2%), and the prognosis is generally poor.","PeriodicalId":92983,"journal":{"name":"Annals of breast cancer and therapy","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Difficult-to-Diagnose Hormone-Negative, Human Epidermal Growth Factor Receptor 2-Positive Poorly-Differentiated Breast Cancer in a Male Patient\",\"authors\":\"Kitada Masahiro, Yasuda Shunsuke, A. Masahiro, Yoshida Nana, Okazaki Satoshi, Ishibashi Kei\",\"doi\":\"10.36959/739/524\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Male breast cancer is rare, accounting for approximately 0.5-1.0% of all cases and is often a hormone-dependent luminal type. The percentage of hormone-negative, human epidermal growth factor receptor 2 (HER2)-positive breast cancer cases is very small in male patients (0.6-1.2%), and the prognosis is generally poor.\",\"PeriodicalId\":92983,\"journal\":{\"name\":\"Annals of breast cancer and therapy\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of breast cancer and therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36959/739/524\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of breast cancer and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36959/739/524","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

男性癌症罕见，约占所有病例的0.5-1.0%，通常是激素依赖性管腔型。激素阴性、人表皮生长因子受体2（HER2）阳性的乳腺癌症病例在男性患者中的百分比很小（0.6-1.2%），预后通常很差。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Difficult-to-Diagnose Hormone-Negative, Human Epidermal Growth Factor Receptor 2-Positive Poorly-Differentiated Breast Cancer in a Male Patient

Male breast cancer is rare, accounting for approximately 0.5-1.0% of all cases and is often a hormone-dependent luminal type. The percentage of hormone-negative, human epidermal growth factor receptor 2 (HER2)-positive breast cancer cases is very small in male patients (0.6-1.2%), and the prognosis is generally poor.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Annals of breast cancer and therapy

自引率

0.00%

发文量